Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Market Capitalization (2017 - 2026)

Dyadic International's (DYAI) quarterly Market Capitalization came in at $29.9 million in Q1 2026, down 26.45% year-over-year from $40.6 million in Q1 2025, and down 12.16% quarter-over-quarter from $34.0 million in Q4 2025.

Analysis

Dyadic International (DYAI) Market Capitalization (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Market Capitalization across 10 years of filings, most recently posting $29.9 million for Q1 2026.

  • In Q1 2026, Market Capitalization fell 26.45% year-over-year to $29.9 million; the TTM figure through Mar 2026 stood at $29.9 million (down 26.45% YoY), while the FY2025 annual figure was $34.0 million, down 34.85% from the prior year.
  • Market Capitalization came in at $29.9 million for Q1 2026 at Dyadic International, down from $34.0 million in the prior quarter.
  • In the past five years, Market Capitalization ranged from a high of $86.2 million in Q2 2022 to a low of $29.8 million in Q2 2025.
  • Average Market Capitalization over 5 years is $48.3 million, with a median of $46.4 million recorded in 2023.
  • Year-over-year, Market Capitalization sank 72.47% in 2022 and jumped 38.76% in 2025.
  • Over 5 years, Market Capitalization stood at $35.1 million in 2022, then soared by 32.03% to $46.4 million in 2023, then rose by 12.56% to $52.2 million in 2024, then tumbled by 34.85% to $34.0 million in 2025, then slipped by 12.16% to $29.9 million in 2026.
  • Per Business Quant data, the three most recent Market Capitalization figures were $29.9 million in Q1 2026, $34.0 million in Q4 2025, and $42.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Dyadic International 17.78 Mn 9.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 29.88 Mn
Dec 31, 2025 34.02 Mn
Sep 30, 2025 42.70 Mn
Jun 30, 2025 29.83 Mn
Mar 31, 2025 40.62 Mn
Dec 31, 2024 52.21 Mn
Sep 30, 2024 30.77 Mn
Jun 30, 2024 43.63 Mn
Mar 31, 2024 48.74 Mn
Dec 31, 2023 46.39 Mn
Sep 30, 2023 55.32 Mn
Jun 30, 2023 55.61 Mn
Mar 31, 2023 51.28 Mn
Dec 31, 2022 35.13 Mn
Sep 30, 2022 54.36 Mn
Jun 30, 2022 86.21 Mn
Mar 31, 2022 85.08 Mn
Dec 31, 2021 127.60 Mn
Sep 30, 2021 156.12 Mn
Jun 30, 2021 100.80 Mn